MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds ...
Hologic’s HOLX Skeletal Health division has been driving positive contributions ever since the earlier supply challenges began to ease. Sales jumped 62.1% in the third quarter of fiscal 2025, driven ...
Hologic HOLX is set to release fourth-quarter fiscal 2025 results on Nov. 3, after the closing bell. The Zacks Consensus Estimate for fiscal fourth-quarter earnings per share (EPS) suggests an 8.9% ...
Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...
Analyst Michael Matson from Needham maintained a Buy rating on Hologic (HOLX – Research Report) and keeping the price target at $90.00. Discover top-rated stocks from highly ranked analysts with ...
In a report released today, Tejas Savant from Morgan Stanley maintained a Hold rating on Hologic (HOLX – Research Report), with a price target of $82.00. The company’s shares closed last Friday at $71 ...
Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue Milestones Represents 46% Premium to Hologic’s Closing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback